Sign in

BSEM on Nasdaq

BioStem Technologies, Inc.

BioStem Technologies, Inc. is an American biological products company based in Pompano Beach.1 Its shares trade on Nasdaq under the symbol BSEM.1

Price unavailable

Last updated Oct 21, 2026.

Overview

Compare with another stock.

  • TickerBSEM on Nasdaq1
  • IndustryBiological Products, (No Diagnostic Substances)1
  • HeadquartersPompano Beach, Florida1
  • Incorporated inFL2
  • Business address2836 Center Port Circle, Pompano Beach, Fl 336042
  • Filer categoryNon-accelerated filer, Smaller reporting company, Emerging growth company2
  • Legal formCorporation

See how the biggest companies compare on our leaderboards

Leadership

Who has led BioStem Technologies, Inc., and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Jason Matuszewski2026–now

Chief financial officer

  1. Brandon Poe2026–now

Chief operating officer

  1. Vurst Andrew Smith-Van2026–now
Board members and other officers (10)

Named in SEC Form D filings

People the company listed in its private-offering notices.

  • Executive Officer, DirectorAndrew Van Vurst named Jun 3, 2026 to Sep 21, 202615
  • Executive Officer, DirectorAndrew Smith-Van Vurst named Apr 4, 202316
  • DirectorRayna Lesser Hannaway named Sep 21, 202615
  • DirectorPatrick J. Daly named Jun 3, 202617
  • DirectorThomas J. Dugan named Jun 3, 202617

Former names

  • BIOSTEM TECHNOLOGIESFeb 1, 2016 to Oct 28, 20252

Timeline

  1. Sep 30, 20268-K Entered a material agreement; Unregistered sale of shares; Regulation FD disclosure18
  2. Sep 18, 20268-K Entered a material agreement; Unregistered sale of shares; Regulation FD disclosure19
  3. Aug 14, 2026New chief executive Jason Matuszewski becomes CEO4
  4. Aug 12, 20268-K Results of operations20
  5. Aug 7, 20268-K Other events21

Calendar

Coming up

  1. Nov 12, 2026Reports results for the quarter ending Sep/2026 A year earlier it reported $0.03 a share, on Nov 13, 2025.22

When it reported results

  1. Aug 12, 2026Reported quarterly or annual results20

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar

Filings

58 filings to the SEC since October 2021: 1 quarterly reports, 4 major events, 26 insider forms, 4 private raises, 23 other. The latest 20:

  1. Oct 13, 2026424B3 PROSPECTUS EDGAR
  2. Oct 9, 2026EFFECT EDGAR
  3. Oct 9, 2026D EDGAR
  4. Oct 9, 20264 EDGAR
  5. Oct 9, 20264 EDGAR
  6. Oct 6, 2026S-8 REGISTRATION STATEMENT EDGAR
  7. Oct 2, 2026S-1 REGISTRATION STATEMENT EDGAR
  8. Sep 30, 20268-K EDGAR
  9. Sep 29, 2026EFFECT EDGAR
  10. Sep 29, 2026424B3 PROSPECTUS EDGAR
  11. Sep 21, 2026D EDGAR
  12. Sep 18, 2026S-1 REGISTRATION STATEMENT EDGAR
  13. Sep 18, 20268-K EDGAR
  14. Sep 17, 20264 EDGAR
  15. Sep 17, 20264 EDGAR
  16. Sep 17, 20264 EDGAR
  17. Sep 17, 20264 EDGAR
  18. Sep 17, 20264 EDGAR
  19. Sep 11, 20264 EDGAR
  20. Aug 28, 20264 EDGAR

The 58 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Funding

Where the company's money came from, by calendar year: private offerings filed with the SEC, federal grants, loans, contracts and other assistance from USAspending.gov, and PPP loans from the SBA. Each bar links to the records below.

Money received by year$2.7M 2023–2026
Money received by yearMoney received by year, 2023–2026: $2.7M in all. Private raises (Form D) $2.7M.$0$1M$2M$3M2023 · Private raises (Form D): $220.0K2023202420252026 · Private raises (Form D): $2.5M2026
Figures by year
YearPrivate raises (Form D)Total
2026$2.5M$2.5M
2023$220.0K$220.0K

Private raises

Private offerings the company reported to the SEC on Form D. The amount is what the latest filing says was sold so far, charted in the year of the first sale. Covers filings since Oct 1, 2021.

  1. Sep 21, 2026Filed a private offering of equity15 Form D: $40 million offered in all Form D
  2. May 21, 2026Raised $2.5 million in a private offering of equity17 Form D: 1 investor so far Form D
  3. Mar 9, 2023Raised $220,002 in a private offering of equity16 Form D: $5 million offered in all Form D

SEC filer profile

How BioStem Technologies, Inc. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARBioStem Technologies, Inc.1
  • CIK0001658678
  • Employer ID (EIN)27-04004161
  • Filer statusNon-accelerated filer<br>smaller reporting company<br>emerging growth company1
  • Incorporated inFlorida1
  • Fiscal year endsDecember 311
  • Industry code (SIC)2836 Biological Products, (No Diagnostic Substances)1
  • SEC reviewing officeOffice of Life Sciences, Division of Corporation Finance1
  • Business address2836 Center Port Circle, Pompano Beach, FL 336041
  • Phone954-380-83421
  • Shares outstanding17,849,471 as of Aug 12, 20263
  • On EDGAR sinceFeb 1, 20161
  • Filings61 in all: 4 (15), 3 (11), D (7), 10-12B/A (4), 424B3 (4), 8-K (4), EFFECT (3), S-1 (3)1
    All 18 form types

    10-12B (1), 10-12G (1), 10-Q (1), CERT (1), DRS (1), DRS/A (1), RW (1), S-1/A (1), S-8 (1), SEC STAFF ACTION (1)

  • Latest filingsQuarterly report (10-Q) Aug 12, 2026
    Latest 8-K (8-K) Sep 30, 2026

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
    SEC EDGAROther events
  22. 22